Wolf-Dieter Heiss Selected Research

Wolf-Dieter Heiss Research Topics

Disease

30	Stroke (Strokes) 01/2022 - 01/2003
12	Infarction (Infarctions) 01/2022 - 05/2002
12	Ischemic Stroke 09/2021 - 05/2002
8	Glioma (Gliomas) 08/2014 - 02/2003
7	Aphasia (Dysphasia) 01/2022 - 01/2013
7	Neoplasms (Cancer) 10/2011 - 10/2003
6	Alzheimer Disease (Alzheimer's Disease) 11/2018 - 01/2002
6	Ischemia 01/2017 - 05/2002
6	Parkinson Disease (Parkinson's Disease) 05/2012 - 01/2003
4	Dementia (Dementias) 01/2017 - 09/2005
4	Glioblastoma (Glioblastoma Multiforme) 02/2010 - 03/2002
4	Brain Neoplasms (Brain Tumor) 01/2010 - 01/2005
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2007 - 05/2002
3	Hypoxia (Hypoxemia) 01/2016 - 10/2011
3	Neuroinflammatory Diseases 11/2014 - 09/2014
3	Cognitive Dysfunction 09/2014 - 09/2005
2	Hemorrhage 01/2021 - 05/2014
2	Mixed Dementias 11/2016 - 11/2012
2	Edema (Dropsy) 01/2016 - 12/2003
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 05/2014 - 01/2003
2	Disease Progression 02/2010 - 01/2007
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	COVID-19 01/2021
1	Embolic Stroke 01/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2014
1	Transient Ischemic Attack 05/2014
1	Embolism (Embolus) 05/2014
1	Inflammation (Inflammations) 09/2012
1	Brain Diseases (Brain Disorder) 10/2010
1	Brain Edema (Cerebral Edema) 01/2007
1	Amyloid Plaque 11/2006
1	Restless Legs Syndrome (Restless Legs) 10/2006
1	Parkinsonian Disorders (Parkinsonism) 10/2006
1	Memory Disorders (Memory Loss) 02/2006

Drug/Important Bio-Agent (IBA)

7	Amino Acids FDA Link 08/2014 - 05/2002
6	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2013
6	Glucose (Dextrose)FDA LinkGeneric 11/2016 - 01/2004
5	cerebrolysinIBA 09/2021 - 03/2012
5	Amyloid (Amyloid Fibrils)IBA 01/2017 - 11/2012
5	Biological ProductsIBA 09/2012 - 10/2003
5	Methionine (L-Methionine)FDA Link 01/2010 - 06/2003
4	thiamine triphosphorate (TTP)IBA 01/2018 - 03/2010
4	Oxygen (Dioxygen)IBA 01/2016 - 11/2004
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2018 - 01/2002
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 11/2004
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2014 - 01/2003
3	Glutamic Acid (Glutamate)FDA Link 03/2005 - 05/2002
3	Ganciclovir (Cytovene)FDA LinkGeneric 10/2003 - 03/2002
2	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 05/2014
2	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 01/2003
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2011
2	NeuropeptidesIBA 04/2018 - 10/2017
2	Flumazenil (Romazicon)FDA LinkGeneric 01/2016 - 08/2004
2	LigandsIBA 11/2014 - 10/2010
2	Cholinergic Agents (Cholinergics)IBA 05/2012 - 11/2006
2	alovudineIBA 06/2011 - 12/2005
2	Ion Pumps (Ion Pump)IBA 01/2011 - 08/2010
2	GABA-A Receptors (GABA(A) Receptor)IBA 10/2010 - 02/2006
2	Temozolomide (Temodar)FDA LinkGeneric 02/2010 - 05/2006
2	ProdrugsIBA 02/2007 - 02/2003
2	Therapeutic UsesIBA 02/2007 - 10/2003
2	EsterasesIBA 11/2006 - 09/2005
2	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2006 - 09/2005
2	Indicators and Reagents (Reagents)IBA 11/2006 - 09/2005
2	gamma-Aminobutyric Acid (GABA)IBA 02/2006 - 03/2005
2	AcetylcholinesteraseIBA 02/2006 - 02/2006
2	fluorodopa F 18IBA 03/2005 - 09/2003
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	Endothelin-1 (Endothelin 1)IBA 01/2016
1	fluoromisonidazoleIBA 01/2016
1	Vasoconstrictor AgentsIBA 01/2016
1	N 30IBA 11/2015
1	Radioisotopes (Radionuclides)IBA 11/2014
1	Clopidogrel (Plavix)FDA Link 05/2014
1	CytokininsIBA 09/2012
1	Lactic Acid (Lactate)FDA LinkGeneric 09/2012
1	Saline SolutionIBA 03/2012
1	NucleosidesIBA 10/2011
1	Staphylococcal Protein A (Protein A)IBA 02/2011
1	9-(4-fluoro-3-hydroxymethylbutyl)guanineIBA 02/2007
1	Apolipoprotein E4IBA 11/2006
1	Dopamine (Intropin)FDA LinkGeneric 10/2006
1	Dopamine Agents (Dopaminergic Agents)IBA 10/2006
1	Serotonin (5 Hydroxytryptamine)IBA 02/2006

Therapy/Procedure

14	Therapeutics 09/2021 - 01/2003
8	Transcranial Magnetic Stimulation 01/2022 - 01/2005
5	Language Therapy (Language Training) 01/2022 - 01/2013
3	Transcranial Direct Current Stimulation 12/2020 - 04/2015
2	Aftercare (After-Treatment) 11/2015 - 08/2013
2	Drug Therapy (Chemotherapy) 02/2010 - 05/2006
2	Deep Brain Stimulation 01/2004 - 01/2003
1	Thrombectomy 01/2021
1	Speech Therapy (Therapy, Speech) 12/2020
1	Injections 01/2016
1	Intravenous Infusions 03/2012
1	Radiotherapy 02/2010
1	Conservative Treatment 01/2007